Skip to main content

5 important things that we know now about corona virus and simple precautions

In a pandemic there’s a greater chance of survival for those getting infected 3 months later like June 2020 than those who got infected 3 months earlier say February 2020. The reason for this is that Doctors and scientists know more about Covid-19 now than 3 months ago and hence are able to treat patients better. I will list 5 important things that we know now that we didn’t know in February 2020 for your understanding. 1. COVID-19 was initially thought to cause deaths due to pneumonia- a lung infection- and so Ventilators were thought to be the best way to treat sick patients who couldn’t breathe. Now we are realising that the virus 🦠 causes blood clots in the blood vessels of the lungs and other parts of the body and this causes the reduced oxygenation . Now we know that just providing oxygen by ventilators will not help but we have to prevent and dissolve the micro clots in the lungs. This is why we are using drugs like *Asprin and Heparin ( blood thinners that prevents clotting) as protocol in treatment regimens in June 2020. * 2. Previously patients used to drop dead on the road or even before reaching a hospital due to reduced oxygen in their blood- OXYGEN SATURATION. This was because of HAPPY HYPOXIA- where even though the oxygen saturation was gradually reducing the COVID-19 patients did not have symptoms until it became critically less, like sometimes even 70%. *Normally we become breathless if oxygen saturation reduces below 90%. **This breathlessness is not triggered in Covid patients and so we we’re getting the sick patients very late to the hospitals in February 2020. Now since knowing about happy hypoxia we are monitoring oxygen saturation of all covid patients *with a simple home use pulse oxymeter and getting them to hospital if their oxygen saturation drops to 93% or less. This gives more time for doctors to correct the oxygen deficiency in the blood and a better survival chance in June 2020. 3. We did not have drugs to fight the corona virus 🦠 in February 2020. We were only treating the complications caused by it... hypoxia. Hence most patients became severely infected. **Now we have 2 important medicines FAVIPIRAVIR & REMDESIVIR** Which are ANTIVIRALS that can kill the corona virus 🦠. By using these two medicines we can prevent patients from becoming severely infected and therefore cure them BEFORE THEY GO TO HYPOXIA. This knowledge we have in JUNE 2020... not in February 2020. 4. Many Covid-19 patients die not just because of the virus 🦠 but also due the patients own immune system responding In an exaggerated manner called CYTOKINE STORM. This stormy strong 💪 immune response not only kills the virus 🦠 but also kills the patients. In February 2020 we didn’t know how to prevent it from happening. Now in June 2020, we know that easily available medicines called Steroids, that doctors around the world have been using for almost 80 years can be used to prevent the cytokine storm in some patients. 5. Now we also know that people with hypoxia became better just by making them lie down on their belly- known as prone position. Apart from this a few days ago Israeli scientists have discovered that a chemical known as Alpha Defensin produced by the patients White blood cells can cause the micro clots in blood vessels of the lungs and this could possibly be prevented by a drug called Colchicine used over many decades in the treatment of Gout. So now we know for sure that patients have a better chance at surviving the COVID-19 infection now in June 2020 than in February 2020 for sure. India has not peaked in March or April because of the lockdown. This strategy has postponed the Covid-19 pandemic in INDIA by 3 crucial months that has enabled us to save thousands of lives. Going forward there’s nothing to panic about Covid-19 if we remember that a person who gets infected later has a better chance at survival than one who got infected early. Let’s all follow simple precautions like -6 feet distancing from others -Wear proper masks -Work from home whenever possible -Order delivery and take away of food groceries and vegetables - Stay at home during lockdown - Hand 🤚 wash & hygiene With this we can beat the virus 🦠. If someone tells you every one is going to get infected, tell them that you are willing to wait to be the last person... who knows by then we might even have a VACCINE.

Comments

Popular posts from this blog

Increased risks of drop out for women and girls : CoronaVirus Updates

The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...

Glenmark's antiviral combination for moderate Covid-19 shows no clinical benefit

Glenmark Pharmaceuticals Ltd on Friday said addition of Umifenovir did not demonstrate any additional benefit over Favipiravir alone in moderate Covid-19 patients. Umifenovir did not show superior clinical outcomes when added to Favipiravir treatment, the trial did not meet key end-points,  the company said. The trial's findings confirm that the addition of Umifenovir does not show any incremental benefit in clinical outcomes, Monika Tandon, senior vice president & head, Clinical Development, Global Specialty/Branded Portfolio at the company, said in a statement , adding that favipiravir alone remains the effective choice for mild to moderate COVID-19 infection. Favipiravir is made under the brand name Avigan by Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug there in 2014, while Umifenovir is licensed as a treatment for some types of flu infections in Russia and China. Fujifilm last month said a late-stage study of Avigan showed i...

No significant benefit of Umifenovir in COVID-19 treatment: Glenmark

Drug firm  Glenmark Pharmaceuticals  on Friday said the addition of  antiviral Umifenovir  did not demonstrate any significant clinical benefit over  Favipiravir  alone in  moderate COVID-19 patients .  The  clinical study  evaluated the possible superiority of the combination's efficacy against Favipiravir monotherapy, Glenmark said in a statement. As per the results that Glenmark presented to the regulator, the study showed no superior clinical outcomes with the addition of Umifenovir, it added. This was the second clinical study after the successful Favipiravir monotherapy trial earlier this year that led the company to receiving the Emergency Use Authorisation for Favipiravir, Glenmark said. "These latest findings confirm that the addition of Umifenovir does not show any incremental benefit in clinical outcomes. Thus Favipiravir therapy along with supportive care remains a suitable and effective choice for mild to moderate COVID-1...